Published in Women's Health Law Weekly, December 14th, 2008
In this open-label study, designed to evaluate the activity of NVC-422 in the bladders of patients with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.